Filing Details

Accession Number:
0001140361-18-024405
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-17 15:26:26
Reporting Period:
2018-05-16
Accepted Time:
2018-05-17 15:26:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70487 National Research Corp NRCI Services-Commercial Physical & Biological Research (8731) 470634000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1248110 N John Nunnelly P.o. Box 2175
Amherst MA 01004
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-16 17,483 $24.35 59,377 No 4 M Direct
Common Stock Disposition 2018-05-16 12,286 $34.65 47,091 No 4 F Direct
Common Stock Disposition 2018-05-16 5,952 $34.67 41,139 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (Right to Buy) Disposition 2018-05-16 17,483 $0.00 17,483 $24.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,821 2018-05-09 2027-05-09 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Director Stock Option (Right to Buy) $9.73 2012-05-06 2021-05-06 28,763 28,763 Direct
Common Stock Director Stock Option (Right to Buy) $16.89 2014-05-09 2023-05-09 36,000 36,000 Direct
Common Stock Director Stock Option (Right to Buy) $14.95 2015-05-08 2024-05-08 36,000 36,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-05-06 28,763 28,763 Direct
2023-05-09 36,000 36,000 Direct
2024-05-08 36,000 36,000 Direct
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $34.05 to $34.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.